News Articles for "Canadian Drugmaker"
Valeant buying skin product maker Obagi for $360M
Valeant Pharmaceuticals is buying dermatology products maker Obagi for about $360 million to build its skin-care business. Valeant, a Canadian drugmaker, ...
read more
Valeant Pharma posts 4Q loss on deal-related costs
Valeant Pharmaceuticals International Inc. reported a fourth-quarter loss, as acquisition-related costs countered steep revenue growth for the Canadian dru...
read more
Oncolytics rises on new cancer drug data
Shares of Oncolytics Biotech Inc. jumped Friday after the company said its drug Reolysin shrunk the tumors of almost all the patients in a small clinical ...
read more
Anacor shares sink after release of study results
Shares of Anacor Pharmaceuticals Inc. plunged Tuesday after the drug developer said its potential nail fungus treatment did better than a placebo in a late...
read more
